中医药抗肝纤维化疗效评价的探索
我国在利用中成药治疗肝纤维化方面已走在国际前列。建议从抗肝纤维化的近期疗效、长期疗效和症状改善疗效3个方面开展评价,并介绍了笔者探索应用肝脏弹性测量值评价中成药抗纤维化的临床疗效,以5年生存率评价长期疗效,以及采用＂中医证候评定量表＂评价症状改善疗效的实践结果,显示出中成药扶正化瘀胶囊/片抗肝纤维化的临床疗效显著。建议配合血清学诊断模型,开展前瞻性的长期随访和对长期积累的大样本、大数据作分析,以完善抗肝纤维化疗效评价方法。...
Saved in:
| Published in | 临床肝胆病杂志 Vol. 33; no. 5; pp. 825 - 828 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海201203
2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1001-5256 |
| DOI | 10.3969/j.issn.1001-5256.2017.05.006 |
Cover
| Abstract | 我国在利用中成药治疗肝纤维化方面已走在国际前列。建议从抗肝纤维化的近期疗效、长期疗效和症状改善疗效3个方面开展评价,并介绍了笔者探索应用肝脏弹性测量值评价中成药抗纤维化的临床疗效,以5年生存率评价长期疗效,以及采用＂中医证候评定量表＂评价症状改善疗效的实践结果,显示出中成药扶正化瘀胶囊/片抗肝纤维化的临床疗效显著。建议配合血清学诊断模型,开展前瞻性的长期随访和对长期积累的大样本、大数据作分析,以完善抗肝纤维化疗效评价方法。 |
|---|---|
| AbstractList | R575.2; 我国在利用中成药治疗肝纤维化方面已走在国际前列.建议从抗肝纤维化的近期疗效、长期疗效和症状改善疗效3个方面开展评价,并介绍了笔者探索应用肝脏弹性测量值评价中成药抗纤维化的临床疗效,以5年生存率评价长期疗效,以及采用“中医证候评定量表”评价症状改善疗效的实践结果,显示出中成药扶正化瘀胶囊/片抗肝纤维化的临床疗效显著.建议配合血清学诊断模型,开展前瞻性的长期随访和对长期积累的大样本、大数据作分析,以完善抗肝纤维化疗效评价方法. 我国在利用中成药治疗肝纤维化方面已走在国际前列。建议从抗肝纤维化的近期疗效、长期疗效和症状改善疗效3个方面开展评价,并介绍了笔者探索应用肝脏弹性测量值评价中成药抗纤维化的临床疗效,以5年生存率评价长期疗效,以及采用＂中医证候评定量表＂评价症状改善疗效的实践结果,显示出中成药扶正化瘀胶囊/片抗肝纤维化的临床疗效显著。建议配合血清学诊断模型,开展前瞻性的长期随访和对长期积累的大样本、大数据作分析,以完善抗肝纤维化疗效评价方法。 |
| Abstract_FL | China has become one of the leading counties in the world to treat hepatic fibrosis with Chinese patent drugs.The therapeutic effect of traditional Chinese medicine (TCM) should be evalvated from the aspects of short-term therapeutic effect,long-term therapeutic effect,and effect of relief of symptoms.This article introduces the results of our exploration of the application of liver stiffness measurement to evaluate therapeutic effect,five-year survival rate to assess]ong-term therapeutic effect,and a "TCM syndrome scale" to evaluate effect of relief of symptoms,suggesting that the Chinese patent drug Fuzheng Huayu capsules/tablets have a marked clinical effect in the treatment of hepatic fibrosis.It is recommended to use serological diagnostic models,conduct prospective studies with long-term follow-up,and analyze the samples and data accumulated over a long period of time,in order to perfect the methods for evaluating the outcome of hepatic fibrosis. |
| Author | 徐列明 |
| AuthorAffiliation | 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海201203 |
| AuthorAffiliation_xml | – name: 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海201203 |
| Author_FL | XU Lieming |
| Author_FL_xml | – sequence: 1 fullname: XU Lieming |
| Author_xml | – sequence: 1 fullname: 徐列明 |
| BookMark | eNo9j01LAkEcxudgkJlfIjp02W1e_-McQ3oDoYv3ZWbHtRWbLZeIPIaHCO2WQtBFuoYXoWi_jrp-jDaMTg88_Hgefjuo5BLXQmifYJ8pUIcdP05T5xOMiSeoAJ9iIn0sfIyhhMr__TaqpmlssCAMFBdQRt7i62M5zNaj2eppsn54y7_f82y-HI7z8WT18rieDRbZZ_46WD1P8_l0F21Fupu2qn9ZQc2T42b9zGtcnJ7XjxpeCBg8DljYFuESQ6SpAipJVOPE1qjUEaOaGCsY0To0VkoWArWcGymsiUKhtFGsgg42s3faRdq1g05y23PFYdAN29b0-796WBRyBbq3QcPLxLVv4gK-7sVXuncfgKSUA5OK_QBDl2RP |
| ClassificationCodes | R575.2 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1001-5256.2017.05.006 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | An exploration of therapeutic evaluation of traditional Chinese medicine in treatment of hepatic fibrosis |
| DocumentTitle_FL | An exploration of therapeutic evaluation of traditional Chinese medicine in treatment of hepatic fibrosis |
| EndPage | 828 |
| ExternalDocumentID | lcgdbzz201705006 672246379 |
| GroupedDBID | -05 2B. 2C~ 2RA 5XA 5XF 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EAD EAP EOJEC ESX GROUPED_DOAJ IPNFZ OBODZ OK1 RIG RNS TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c606-4605de14706fa296271f841d827af32a1bd531aacbd773c62d44b75dbfc59ab93 |
| ISSN | 1001-5256 |
| IngestDate | Thu May 29 03:59:50 EDT 2025 Wed Feb 14 10:02:16 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | 治疗结果 中成药 treatment outcome 肝硬化 liver cirrhosis Chinese patent drugs |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c606-4605de14706fa296271f841d827af32a1bd531aacbd773c62d44b75dbfc59ab93 |
| Notes | liver cirrhosis; Chinese patent drugs; treatment outcome XU Lieming. （ Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine ＆ Institute of ltepatology, Shanghai Uni- versity of Traditional Chinese Medicine, Shanghai 201203, China） China has become one of the leading counties in the world to treat hepatic fibrosis with Chinese patent drugs. The therapeutic effect of traditional Chinese medicine （TCM） should be evaluated from the aspects of short -term therapeutic effect, long- term therapeutic effect, and effect of relief of symptoms. This article introduces the results of bur exploration of the application of liver stiffness measurement to evaluate therapeutic effect, five -year survival rate to assess long - term therapeutic effect, and a ＂TCM syndrome scale＂ to evaluate effect of relief of symptoms, suggesting that the Chinese patent drug Fuzheng Huayn capsules/tablets have a marked clinical effect in the treatment of hepatic fibrosis. It is recommended to use serological diagno |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_lcgdbzz201705006 chongqing_primary_672246379 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 临床肝胆病杂志 |
| PublicationTitleAlternate | Chinese Journal of Clinical Hepatology |
| PublicationTitle_FL | Journal of Clinical Hepatology |
| PublicationYear | 2017 |
| Publisher | 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海201203 |
| Publisher_xml | – name: 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海201203 |
| SSID | ssib051369456 ssj0041983 ssib001103858 ssib053243598 ssib002264326 ssib038074677 |
| Score | 2.085944 |
| Snippet | 我国在利用中成药治疗肝纤维化方面已走在国际前列。建议从抗肝纤维化的近期疗效、长期疗效和症状改善疗效3个方面开展评价,并介绍了笔者探索应用肝脏弹性测量值评价中成药抗... R575.2; 我国在利用中成药治疗肝纤维化方面已走在国际前列.建议从抗肝纤维化的近期疗效、长期疗效和症状改善疗效3个方面开展评价,并介绍了笔者探索应用肝脏弹性测量值评价... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 825 |
| SubjectTerms | 中成药 治疗结果 肝硬化 |
| Title | 中医药抗肝纤维化疗效评价的探索 |
| URI | http://lib.cqvip.com/qk/90100X/201705/672246379.html https://d.wanfangdata.com.cn/periodical/lcgdbzz201705006 |
| Volume | 33 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate issn: 1001-5256 databaseCode: ABDBF dateStart: 20130401 customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn omitProxy: true ssIdentifier: ssj0041983 providerName: EBSCOhost – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources issn: 1001-5256 databaseCode: M~E dateStart: 19850101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://road.issn.org omitProxy: true ssIdentifier: ssib053243598 providerName: ISSN International Centre |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSxxBEG6MguQS8iTGJBiwjmN2unv6cZxxZ5GAORnwtsxTD2HNQy97DB5CMLlFIZCL5Bq8CAnx76i7PyNVPbPrRERMAkvT1FZXVXfNTFUPXd8wNt8qipJwPjyRmcKT1hdemuXck4aXhmopVUG1w8vP1dIL-Ww1WJ241jy1tLWZLmT9C-tK_sWrSEO_UpXsX3h2LBQJ2Ef_YosexvZKPoZYQmQgbEMcgFmEKILYgGlD2IFYgQnBakfhYJFHQxRCKF0ngkjWo6wiCrbEjC0SDY1CIUY6FcisHU_oKCg5hpA7ORI7zQS3NqkSjurQhjMDsCPAVOo0mMCpa9O_xNwBOw6KjhCDbTkbzcg0FBA331NUBZnumqoVkz4FUeAsvmR1AlqIULsOUtAmC9a66eFYH2zsFEZEpOH4sw05jhmXgC_-t96Ge-pF0RC2wDo_hRYi5Vbc0pmUi9RxKkwWjeBCx9cCXgGpj6KPEI27LGiEElMVhI-ykqqE_nzAE1ZZF_BIwcJYAR1ZrBBpW-dwxl3m8jJby9N-nzssJQdYP8XpddYkmwqjdtQ5y6f91h9gR1R13cj36WMFsoGHGPhCWXkGzhRgtk4IkaPUSPrWVBUvtZ3TbL6exNPLpkC4J-sbvbXXmM254rpemfTWGnngyk12o97AzYXV3XiLTfTXb7Pp5fqIyh3mHf_8frJzNPx4cPphb_ju6-DXt8HR4cnO7mB37_Tz--HB9vHRj8GX7dNP-4PD_btspROvLC559TdJvAy3-h6dIsgLX-qWKhNOH67ySyP93HCdlIInfppjUEuSLM21FpniuZSpDvK0zAKbpFbcY5O9jV5xn83ltjSZ5X5SpFwqxdMMNzOlKDnG4JIXaobNjifdfVVBz3SVJgBIoe0Me1IvQ7d-IL3tnnfrgyvwzLLr1K9eKj5kk5tvtopHmGZvpo_ri-E3yqyV-A |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E4%B8%AD%E5%8C%BB%E8%8D%AF%E6%8A%97%E8%82%9D%E7%BA%A4%E7%BB%B4%E5%8C%96%E7%96%97%E6%95%88%E8%AF%84%E4%BB%B7%E7%9A%84%E6%8E%A2%E7%B4%A2&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%BE%90%E5%88%97%E6%98%8E&rft.date=2017&rft.pub=%E4%B8%8A%E6%B5%B7%E4%B8%AD%E5%8C%BB%E8%8D%AF%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E6%9B%99%E5%85%89%E5%8C%BB%E9%99%A2%2C%E4%B8%8A%E6%B5%B7%E4%B8%AD%E5%8C%BB%E8%8D%AF%E5%A4%A7%E5%AD%A6%E8%82%9D%E7%97%85%E7%A0%94%E7%A9%B6%E6%89%80%2C%E4%B8%8A%E6%B5%B7201203&rft.issn=1001-5256&rft.volume=33&rft.issue=5&rft.spage=825&rft.epage=828&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2017.05.006&rft.externalDocID=lcgdbzz201705006 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90100X%2F90100X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg |